Clinical trials: Introduction

Journal of Internal Medicine

Volumn 254, Issue 2, 2003, Pages 103-104

  Held, P ^a   Wedel, H ^a   Wilhelmsen, Lars ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ESTROGEN; POLIOMYELITIS VACCINE;

CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUSTRY; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE FINANCING; HUMAN; MEDICAL LITERATURE; METHODOLOGY; POLIOMYELITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; HUMANS; RANDOMIZED CONTROLLED TRIALS; RESEARCH;

EID: 0042845700     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01202.x     Document Type: Editorial

References (6)

1. Bigger JT, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. Multi-center Post-Infarction Research group. The relationships among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Circulation 1984; 69: 250-8.
2. The Cardiac suppression Trial (CAST) Investigators. Preliminary report: effect of Encainide and Flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406-12.
3. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
4. Sidney S, Petitti DB, Quesenberry CP. Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women. Ann Intern Med 1997; 127: 501-8.
5. Hulley S, Grady D, Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/progestin replacement study research group. JAMA 1998; 280: 605-13.
6. Heckbert SR, Kaplan RC, Weiss NS et al. Risk of recurrent coronary events in relation to use and recent initiation of postmenopansal hormone therapy. Arch Intern Med 2001; 161: 1709-13.